FX Shoulder Solutions Retrospective / Prospective Clinical Study
Recruiting · NCT06077942
Conditions: Rotator Cuff Syndrome of Shoulder and Allied Disorders, Osteoarthritis Shoulder, Fracture, Shoulder
At a glance
- Research payments reported, 2025
- $232,517
- U.S. investigators named
- 0
- Sites paid
- 0
- Planned or actual enrollment
- 600
About the trial
- Sponsor
- FX Shoulder Solutions
- Tested
- FX Artificial Shoulder Prosthesis (device)
- Dates
- Started 2022-12-06; completion 2032-12-30
- Results posted
- Not yet
Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
From ClinicalTrials.gov, last updated 2023-10-12. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Fx Shoulder Solutions, Inc reported $232,517 in research payments for this study in 2025 (4 payments).
Products named: Fx V135, Fx V 135
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $232,517
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.